SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 39 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,984,976 | +4.7% | 5,082,000 | 0.0% | 0.04% | -4.8% |
| Q2 2023 | $8,580,143 | -37.4% | 5,082,000 | -28.2% | 0.04% | -39.1% |
| Q1 2023 | $13,695,632 | -24.7% | 7,080,000 | -51.2% | 0.07% | -22.5% |
| Q2 2022 | $18,198,000 | -4.5% | 14,500,000 | 0.0% | 0.09% | +71.2% |
| Q1 2022 | $19,049,000 | – | 14,500,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 53,865,000 | $101,127,280 | 3.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | $165,397,613 | 3.42% |
| Boussard & Gavaudan Investment Management LLP | 11,898 | $21,871,538 | 2.42% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,394,000 | $71,834,226 | 1.71% |
| WOLVERINE ASSET MANAGEMENT LLC | 79,876,000 | $149,367,384 | 1.55% |
| CSS LLC/IL | 4,747,000 | $8,868,606 | 0.50% |
| Opti Capital Management, LP | 3,000,000 | $5,611,938 | 0.48% |
| Verition Fund Management LLC | 16,459,000 | $30,786,560 | 0.48% |
| Aequim Alternative Investments LP | 5,000,000 | $9,352,500 | 0.25% |
| MIZUHO SECURITIES USA LLC | 1,097,000 | $2,047,616 | 0.19% |